课题基金 / 基金详情

Biomarkers of ANTidepressant RESponse : early indicators and novel targets

Biomarkers of ANTidepressant RESponse : early indicators and novel targets
抗抑郁药反应的生物标志物：早期指标和新目标
批准号：
407620
负责人：
Turecki Gustavo X
金额：
$8.17万
依托单位：
CIUSSS de l'Ouest-de-l'Ile-de-Montral-Douglas Hospital
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-06-01 至 2022-06-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=407620&lang=en
关键词：
Antidepressant Response Gene Expression Major Depressive Disorder Peripheral Biomarkers

项目摘要

项目成果

Turecki Gustavo X的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antidepressants (AD) are for now, the best treatment we have for major depression (MDD) a severe mental disorder. AD are one of the most commonly prescribed drugs in the western hemisphere, however their trial-and error nature combined with unwanted side-
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extracellular vesicles (EVs) as a window into the depressed brain: an investigation of brain-cell derived EVs
Single-cell, high-throughput characterization of the depressed brain
Canada Research Chair - Tier 1
  • 批准号：
    481064
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2022
  • 负责人：
    Turecki Gustavo X
  • 依托单位：
    McGill University
Extracellular vesicles (EVs) as a window into the depressed brain: an investigation of brain-cell derived EVs
海外基金